Logo image of NB

NIOCORP DEVELOPMENTS LTD (NB) Stock Fundamental Analysis

NASDAQ:NB - Nasdaq - CA6544846091 - Common Stock - Currency: USD

2.36  -0.02 (-0.84%)

After market: 2.3201 -0.04 (-1.69%)

Fundamental Rating

1

Overall NB gets a fundamental rating of 1 out of 10. We evaluated NB against 154 industry peers in the Metals & Mining industry. While NB seems to be doing ok healthwise, there are quite some concerns on its profitability. NB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NB had negative earnings in the past year.
NB had a negative operating cash flow in the past year.
In the past 5 years NB always reported negative net income.
In the past 5 years NB always reported negative operating cash flow.
NB Yearly Net Income VS EBIT VS OCF VS FCFNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

With a Return On Assets value of -41.74%, NB is not doing good in the industry: 87.66% of the companies in the same industry are doing better.
NB has a worse Return On Equity (-108.14%) than 88.31% of its industry peers.
Industry RankSector Rank
ROA -41.74%
ROE -108.14%
ROIC N/A
ROA(3y)-98.84%
ROA(5y)-70.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NB Yearly ROA, ROE, ROICNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

NB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NB Yearly Profit, Operating, Gross MarginsNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for NB has been increased compared to 1 year ago.
NB has more shares outstanding than it did 5 years ago.
NB has a better debt/assets ratio than last year.
NB Yearly Shares OutstandingNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NB Yearly Total Debt VS Total AssetsNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

NB has an Altman-Z score of -8.26. This is a bad value and indicates that NB is not financially healthy and even has some risk of bankruptcy.
NB's Altman-Z score of -8.26 is on the low side compared to the rest of the industry. NB is outperformed by 92.86% of its industry peers.
There is no outstanding debt for NB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.26
ROIC/WACCN/A
WACCN/A
NB Yearly LT Debt VS Equity VS FCFNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

NB has a Current Ratio of 0.19. This is a bad value and indicates that NB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of NB (0.19) is worse than 92.21% of its industry peers.
A Quick Ratio of 0.19 indicates that NB may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.19, NB is doing worse than 92.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
NB Yearly Current Assets VS Current LiabilitesNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

NB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.22%, which is quite impressive.
EPS 1Y (TTM)85.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.99%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -12.73% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y22.64%
EPS Next 2Y2.69%
EPS Next 3Y-12.73%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NB Yearly Revenue VS EstimatesNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 200K 400K 600K
NB Yearly EPS VS EstimatesNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NB Price Earnings VS Forward Price EarningsNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NB Per share dataNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3

4.3 Compensation for Growth

A cheap valuation may be justified as NB's earnings are expected to decrease with -12.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.69%
EPS Next 3Y-12.73%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NIOCORP DEVELOPMENTS LTD

NASDAQ:NB (5/20/2025, 8:19:46 PM)

After market: 2.3201 -0.04 (-1.69%)

2.36

-0.02 (-0.84%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)09-18 2025-09-18/amc
Inst Owners6.86%
Inst Owner Change44.05%
Ins Owners6.44%
Ins Owner Change9.49%
Market Cap127.89M
Analysts84
Price Target4.21 (78.39%)
Short Float %2.85%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.79%
PT rev (3m)13.79%
EPS NQ rev (1m)-175%
EPS NQ rev (3m)-175%
EPS NY rev (1m)-12.5%
EPS NY rev (3m)-12.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 18.56
P/tB 18.56
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0
BVpS0.13
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.74%
ROE -108.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-98.84%
ROA(5y)-70.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z -8.26
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.99%
EPS Next Y22.64%
EPS Next 2Y2.69%
EPS Next 3Y-12.73%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.61%
EBIT Next 3Y15.68%
EBIT Next 5Y97.22%
FCF growth 1Y-24.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.31%
OCF growth 3YN/A
OCF growth 5YN/A